Wells Fargo & Company Taro Pharmaceutical Industries LTD Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$40.97 - $43.33 $33,513 - $35,443	818 Added 29.64%	3,578 $151,000
Q4 2023 Feb 09, 2024	BUY	$32.77 - $42.31 $16,024 - $20,689	489 Added 21.53%	2,760 $115,000
Q3 2023 Nov 13, 2023	SELL	$35.46 - $40.13 $27,836 - $31,502	-785 Reduced 25.69%	2,271 $85,000
Q2 2023 Aug 15, 2023	BUY	$24.24 - $40.97 $74,077 - $125,204	3,056 New	3,056 $115,000
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $51,933 - $72,099	-1,807 Reduced 93.87%	118 $4,000
Q2 2022 Aug 12, 2022	SELL	$35.0 - $43.59 $13,545 - $16,869	-387 Reduced 16.74%	1,925 $70,000
Q1 2022 May 16, 2022	SELL	$43.12 - $50.3 $68,560 - $79,977	-1,590 Reduced 40.75%	2,312 $100,000
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $53,169 - $72,605	-1,117 Reduced 22.26%	3,902 $195,000
Q3 2021 Nov 15, 2021	BUY	$62.34 - $73.38 $32,541 - $38,304	522 Added 11.61%	5,019 $319,000
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $60,283 - $65,757	-858 Reduced 16.02%	4,497 $324,000
Q1 2021 May 13, 2021	BUY	$70.48 - $79.95 $19,170 - $21,746	272 Added 5.35%	5,355 $394,000
Q4 2020 Feb 09, 2021	SELL	$54.4 - $73.42 $15,395 - $20,777	-283 Reduced 5.27%	5,083 $373,000
Q3 2020 Nov 05, 2020	BUY	$54.41 - $68.2 $216,497 - $271,367	3,979 Added 286.88%	5,366 $294,000
Q2 2020 Aug 13, 2020	SELL	$61.66 - $70.16 $12,516 - $14,242	-203 Reduced 12.77%	1,387 $93,000
Q1 2020 May 14, 2020	BUY	$59.35 - $88.73 $94,366 - $141,080	1,590 New	1,590 $98,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.